Hosted on MSN25d
Controversial Martin Shkreli Says IONQ and RGTI Stocks Could Be ‘Best Shorts’: Should You Buy or Sell These Quantum Computing Names Now?The quantum computing sector was shaken after Martin Shkreli, a well-known but controversial figure, took aim at two big names in the industry. On Jan. 21, 2025, Shkreli labeled his bet against ...
Given that Martin Shkreli has a lifetime restraining order preventing him from working in the pharma industry, it will raise a few eyebrows that his new company – launched just two months after ...
Former hedge fund manager Martin Shkreli cast doubt on recent quantum computing advances and stock valuations, particularly targeting IonQ Inc. IONQ and Rigetti Computing Inc. RGTI in a series of ...
In a Spaces interview on X, 'Pharma Bro' Martin Shkreli alleged that he created the DJT cryptocurrency with Barron Trump. Convicted Pharma Bro Martin Shkreli makes surprise appearance at SBF trial ...
Former hedge fund manager Martin Shkreli called quantum computing stocks IonQ Inc. IONQ and Rigetti Computing Inc. RGTI “one of the best shorts” of his career, despite both companies seeing ...
Former Forbes ‘30 Under 30’ star Charlie Javice faces trial for fraud over her $175m sale of student loan startup Frank to JP ...
Martin Shkreli told his X followers that Popcat’s price would go down, but experts still believe other meme coins.
‘Pharma bro’ Martin Shkreli has already found himself back in the spotlight of the law, less than a year after being released from prison for securities fraud. The Federal Trade Commission ...
The "Shkreli Awards" are a kind of Oscars for the most outrageous examples of greed, fraud, and general brokenness in American health care. The awards are named after Martin Shkreli, a former ...
A New York federal judge ordered Martin Shkreli to surrender any copies of the one-of-a-kind Wu-Tang Clan album "Once Upon a Time in Shaolin" in response to a complaint from the record's new owner.
Martin Shkreli was sentenced to seven years in prison last year for looting a drug company he founded, Retrophin, of $11 million to pay back investors in two failed hedge funds he ran. Martin ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results